Shosha E I Dekker

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial

J. D. de Fijter, J. Wetzels, R. Zietse, 2018, JAMA.

Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor–Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients

J. D. de Fijter, J. Wetzels, R. Zietse, 2019, Kidney international reports.

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.

J. D. de Fijter, J. Wetzels, R. Zietse, 2019, Gastroenterology.

Effects of Water Loading on Observed and Predicted Plasma Sodium, and Fluid and Urine Cation Excretion in Healthy Individuals.

L. Vogt, R. O. Olde Engberink, Shosha E I Dekker, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease: a retrospective case series

J. D. de Fijter, H. Wertheim, J. Drenth, 2020, The Journal of antimicrobial chemotherapy.

Change in Urinary Myoinositol/Citrate Ratio Associates with Progressive Loss of Renal Function in ADPKD Patients

J. D. de Fijter, D. Peters, O. Mayboroda, 2022, American Journal of Nephrology.